Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 4/20 | 0.56 |
| ▸ | TSHR | P16473 | 3/20 | 0.56 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.56 |
| ▸ | PDCD1 | Q15116 | 3/20 | 0.53 |
| ▸ | CD274 | Q9NZQ7 | 3/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.46 |
| ▸ | ESR1 | P03372 | 1/20 | 0.44 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 3/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.40 |
| ▸ | CD44 | P16070 | 1/20 | 0.39 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.34 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL10983053 | 0.98 | CYP3A4 (0.54) | CYP3A4TSHRPIK3CAPDCD1CD274 | |
| SCHEMBL27588386 | 0.89 | CD44 (0.50) | CYP3A4TSHRPIK3CAPDCD1CD274 | |
| SCHEMBL27606043 | 0.84 | ALDH1A1 (0.47) | CYP3A4TSHRPIK3CAPDCD1CD274 | |
| SCHEMBL6424004 | 0.83 | PDCD1 (0.64) | PDCD1CD274ESR1APOBEC3GCYP1A2 | |
| SCHEMBL3341757 | 0.83 | CYP3A4 (0.52) | CYP3A4TSHRPIK3CAPDCD1CD274 | |
| SCHEMBL840872 | 0.81 | CYP3A4 (0.62) | CYP3A4TSHRPIK3CAPDCD1CD274 | |
| SCHEMBL5929976 | 0.79 | CYP3A4 (0.59) | CYP3A4TSHRPIK3CAALDH1A1ESR1 | |
| SCHEMBL7406902 | 0.79 | CYP3A4 (0.59) | CYP3A4TSHRPIK3CAALDH1A1ESR1 | |
| SCHEMBL25259982 | 0.77 | CYP3A4 (0.56) | CYP3A4TSHRPIK3CAPDCD1CD274 | |
| SCHEMBL14115801 | 0.77 | PDCD1 (0.53) | TSHRPDCD1CD274APOBEC3GCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 310 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3911795-B1 | METHOD OF STRENGTHENING NON-KERATINOUS FIBERS, AND USES THEREOF | ISP INVESTMENTS LLC (US) | 2025-10-01 | — | — | EP | claimed |
| CN-113646479-B | Method for strengthening non-keratin fibers and use thereof | 埃斯普投资有限公司 | 2023-06-13 | — | — | CN | claimed |
| US-20220120031-A1 | METHOD OF STRENGTHENING NON-KERATINOUS FIBERS, AND USES THEREOF | ISP INVESTMENTS LLC (US) | 2022-04-21 | — | — | US | claimed |
| EP-3911795-A1 | METHOD OF STRENGTHENING NON-KERATINOUS FIBERS, AND USES THEREOF | ISP Investments LLC (US) | 2021-11-24 | — | — | EP | claimed |
| CN-113646479-A | Method for strengthening non-keratin fibers and use thereof | 埃斯普投资有限公司 | 2021-11-12 | — | — | CN | claimed |
| EP-3565523-B1 | METHOD FOR COLORING OR BLEACHING HAIR FIBERS | HERCULES LLC (US) | 2021-09-08 | — | — | EP | claimed |
| CN-112621013-B | Soldering tin bar special for solar photovoltaic solder strip and preparation method thereof | 常州福伦特无铅焊料有限公司 | 2021-07-20 | — | — | CN | claimed |
| CN-112621013-A | Soldering tin bar special for solar photovoltaic solder strip and preparation method thereof | 常州福伦特无铅焊料有限公司 | 2021-04-09 | — | — | CN | claimed |
| WO-2020150384-A1 | METHOD OF STRENGTHENING NON-KERATINOUS FIBERS, AND USES THEREOF | ISP INVESTMENTS LLC (US) | 2020-07-23 | — | — | WO | claimed |
| EP-3565523-A1 | METHOD FOR COLORING OR BLEACHING HAIR FIBERS | Hercules LLC (US) | 2019-11-13 | — | — | EP | claimed |
| EP-2486115-B1 | ELECTRORHEOLOGIC FLUID COMPRISING ORGANIC SUBSTANCES THAT CAN BE DOPED AND USE THEREOF | FRAUNHOFER GES FORSCHUNG (DE) | 2015-05-20 | — | — | EP | claimed |
| US-8288552-B2 | Dihydropyridone amidesas P2X7 modulators | ROCHE PALO ALTO LLC (US) | 2012-10-16 | — | — | US | claimed |
| US-7547713-B2 | O-pyridinequinone derivatives, the composition containing the derivatives, the process for preparation of the derivatives and the use of the derivatives | GU LIANQUAN | 2009-06-16 | — | — | US | claimed |
| EP-1773768-A4 | PYRROLE DERIVATIVES AS PHARMACEUTICAL AGENTS | EXELIXIS INC (US) | 2008-08-06 | — | — | EP | claimed |
| EP-1773768-A2 | PYRROLE DERIVATIVES AS PHARMACEUTICAL AGENTS | Exelixis, Inc. (US) | 2007-04-18 | — | — | EP | claimed |
| US-20060111405-A1 | O-pyridinequinone derivatives, the composition containing the derivatives, the process for preparation of the derivatives and the use of the derivatives | GU LIANQUAN | 2006-05-25 | — | — | US | claimed |
| WO-2006012642-A2 | PYRROLE DERIVATIVES AS PHARMACEUTICAL AGENTS | EXELIXIS, INC. (US) | 2006-02-02 | — | — | WO | claimed |
| EP-1422218-A1 | ANTIVIRAL AGENT | SHIONOGI & CO., LTD. (JP) | 2004-05-26 | — | — | EP | claimed |
| US-6509393-B2 | Phase change inks | XEROX CORPORATION | 2003-01-21 | — | — | US | claimed |
| US-20020137816-A1 | Phase change inks | XEROX CORPORATION | 2002-09-26 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060111405-A1 | O-pyridinequinone derivatives, the composition containing the derivatives, the process for preparation of the derivatives and the use of the derivatives | PTGS2, PTGES2, PTGES | CYP3A4 32/4885TSHR 4772/4885PIK3CA 450/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.